Form 4: 60 Degrees Pharmaceuticals CEO Acquires and Disposes of Shares
SEC Form 4 Filing
Geoffrey S. Dow, CEO of 60 Degrees Pharmaceuticals, reports acquiring and disposing of common stock on January 17, 2025.
Summary
- On January 17, 2025, Geoffrey S. Dow, the President and CEO of 60 Degrees Pharmaceuticals, engaged in transactions involving the company's common stock.
- Dow acquired 14,394 shares of common stock at a price of $0.
- Following the reported transactions, Dow directly owns 108,974 shares of common stock.
- Dow also indirectly owns 55,596 shares through the Geoffrey S. Dow Revocable Trust, for which he serves as trustee.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions by a company executive.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may be interested in this information as it provides insight into the actions of the company's CEO.
Key Dates
| Date | Description |
|---|---|
| 01/17/2025 | Date of the transaction involving the acquisition and disposal of common stock. |
| 01/21/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Geoffrey S. Dow, 60 Degrees Pharmaceuticals, SXTP, Common Stock, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.